Latest News about Medical biotechnology industry
Recent news which mentions Medical biotechnology industry
Humana turns to game theory for new Medicare pricing as insurers juggle Trump rebate uncertainty
March 22, 2019
Tickers
HUM
From CNBC.com News
Biogen stock plunge shows 'investment model in drug development is all wrong,' says former Aetna CEO
March 22, 2019
From CNBC.com News
Tickers
LIFE
From CNBC.com News
From CNBC.com News
Tickers
MO
From CNBC.com News
From CNBC.com News
Johnson & Johnson shares slip after jury orders it to pay $29 million in latest talcum cancer trial
March 14, 2019
Tickers
JNJ
Tags
Places/North America/United States/New Jersey
Health care industry
Medical biotechnology industry
From CNBC.com News
Johnson & Johnson shares slip after jury orders it to pay $29 million in latest talcum cancer trial
March 13, 2019
Tickers
JNJ
Tags
Life and Leisure/Lawsuits
Health Care/Pharmaceuticals Biotechnology and Life Sciences
Biotechnology
From CNBC.com News
From CNBC.com News
Aurora Cannabis chairman describes Nelson Peltz partnership, plans for consumer expansion
March 13, 2019
Tags
Investing/Wall Street
Health Care/Pharmaceuticals Biotechnology and Life Sciences/Pharmaceuticals
PepsiCo Inc/
From CNBC.com News
From CNBC.com News
Marijuana stocks rally after New Jersey governor, lawmakers unveil plan for legal weed
March 12, 2019
Tags
Politics and Government
Places/North America/United States/New Jersey
People/Newsmakers/Leon Cooperman
From CNBC.com News
Measles, once eradicated from the US, reported in 12 states. Outbreak spreads in Brooklyn
March 12, 2019
Tags
Health Care
Health Care/Pharmaceuticals Biotechnology and Life Sciences/Pharmaceuticals
Health care industry
From CNBC.com News
Biotech shares continue to fall on FDA uncertainty
March 07, 2019
Tags
iShares Nasdaq Biotechnology ETF
GlaxoSmithKline PLC
Politics and Government/Government Agencies/FDA
From CNBC.com News
Biotech stocks fall after FDA chief Scott Gottlieb resigns
March 06, 2019
From CNBC.com News
Bristol-Myers urges shareholders in open letter to support $74 billion Celgene deal amid resistance
March 06, 2019
From CNBC.com News
Americans want lower prescription prices, but not if it means fewer drugs, survey finds
March 06, 2019
Tickers
ABBV
Tags
Politics and Government
Politics and Government/Government Agencies/Congress
Breaking News: Business
From CNBC.com News
Tickers
AMZN
From CNBC.com News
Oxycontin-maker Purdue Pharma reportedly exploring bankruptcy amid litigation over opioids
March 04, 2019
From CNBC.com News
Bristol-Myers tries to salvage $74 billion deal with Celgene. Meets with investors in NYC, Boston
February 28, 2019
From CNBC.com News
Activist investor Starboard Value says it will oppose Bristol-Myers' deal for Celgene
February 28, 2019
From CNBC.com News
Martha Stewart partnering with marijuana grower Canopy Growth to develop hemp-derived products
February 28, 2019
Tags
Sequential Brands Group Inc
People/Political Leaders/Andrew Cuomo
Health Care/Pharmaceuticals Biotechnology and Life Sciences/Pharmaceuticals
From CNBC.com News
Senate panel grills pharma CEO over executive bonuses. Calls ties to sales of Humira 'problematic'
February 26, 2019
From CNBC.com News
Sen. Wyden grills pharma execs for raising prices, protecting patents 'like Gollum with his ring'
February 26, 2019
From CNBC.com News
Pharma execs offer Senate ideas to lower drug costs – except actually cutting prices
February 26, 2019
Tags
Breaking News: Business
Politics and Government/Government Agencies/Congress
Medical biotechnology industry
From CNBC.com News
Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakers
February 25, 2019
From CNBC.com News
'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA Chief says
February 25, 2019
From CNBC.com News
Drug pricing showdown: Pharma CEOs set to testify before Congress on Capitol Hill Tuesday
February 25, 2019
Tags
Health Care/Pharmaceuticals Biotechnology and Life Sciences
Prescription drug costs
Politics and Government/Government Programs/Medicare
From CNBC.com News
Danaher to buy General Electric's bio pharma business Life Sciences for $21.4 billion
February 24, 2019
From CNBC.com News
Roche to buy gene therapy specialist Spark in $4.3 billion deal
February 24, 2019
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.